Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

AI-Assisted Anaerobic Threshold Interpretation in Cardiopulmonary Exercise Testing (PACE-Reader)

16 de septiembre de 2026 actualizado por: Shanghai Zhongshan Hospital

A Randomized Two-Period Crossover Reader Study of Artificial Intelligence-Assisted Anaerobic Threshold Interpretation in Cardiopulmonary Exercise Testing

This prospective randomized two-period crossover reader study will evaluate whether assistance from a frozen artificial intelligence model improves physicians' interpretation of the anaerobic threshold (AT) in cardiopulmonary exercise testing (CPET). Sixteen physicians, including 8 senior and 8 junior readers, will each interpret 150 de-identified CPET examinations once without AI assistance and once with AI assistance. The primary outcome is the within-physician difference in absolute AT localization error between the assisted and unassisted conditions. Secondary outcomes include signed timing error, agreement on whether AT is present, estimates within 15 and 30 seconds of the reference, inter-reader reliability, interpretation time, and whether the effect of AI assistance differs by physician seniority.

Descripción general del estudio

Descripción detallada

The 150 de-identified CPET examinations will be divided into two non-overlapping case libraries, X and Y, with 75 examinations in each library. The libraries will be balanced, as far as feasible, by clinical severity and acquisition characteristics. None of the reader-study examinations will be used for model training, hyperparameter selection, or checkpoint selection.

Within each seniority stratum, physicians will be randomized in a 1:1 ratio to Sequence A or Sequence B. In period 1, Sequence A will interpret library X without AI assistance and library Y with AI assistance; Sequence B will receive the opposite conditions. Following a 14 ± 3 day washout, the assistance conditions will be reversed in period 2. Case order will be randomized within each period, and new blinded task identifiers will be assigned in period 2. Thus, every physician will interpret every examination once without AI assistance and once with AI assistance, yielding 4,800 interpretations.

In the assisted condition, the interface will display the frozen model's predicted AT time. In the unassisted condition, no model output will be shown. Readers will be masked to case source, routine-report and reference-standard labels, other readers' annotations, and their own annotations from the previous period. For each examination, the reader will classify AT as confirmed, not reached, or unable to confirm. When AT is confirmed, the reader will record the AT time and the interpretive method used. Interpretation time will also be recorded.

The reference standard will be prespecified from unassisted senior-physician annotations. AT will be considered present when at least 6 of 8 senior physicians confirm it, and the reference AT time will be the median of the confirming senior estimates. AT will be considered not reached when at least 6 of 8 senior physicians make that classification. Discordant cases will undergo adjudication by an additional senior physician who is masked to model output and reader identity. For analyses of senior readers, a leave-one-reader-out reference will be used.

The primary analysis will compare absolute AT localization error between assisted and unassisted interpretations using a crossed mixed-effects model. Fixed effects will include assistance condition, physician seniority, the assistance-by-seniority interaction, period, randomized sequence, and case library. Random intercepts will be included for physician and examination. Estimates will be reported with 95% confidence intervals. No simulated or pilot-result data will be included in the prospective study analysis.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

16

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Porcelana, 200032
        • Zhongshan Hospital, Fudan University
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Age 18 years or older.
  • Licensed physician or physician enrolled in a recognized postgraduate clinical training program at the study institution.
  • Eligible for one of the two prespecified seniority strata: senior physicians are attending physicians or above with at least 5 years of independent CPET interpretation experience; junior physicians are residents or specialty trainees with less than 5 years of independent CPET interpretation experience.
  • Able to interpret CPET examinations and use the study interface after standardized orientation.
  • Willing and able to complete both study periods and the prespecified washout interval.
  • Provides written informed consent.

Exclusion Criteria:

  • Direct involvement in development, training, hyperparameter selection, or checkpoint selection of the PACE-Former model.
  • Prior access to the study case libraries, reference-standard annotations, or model outputs for the study examinations.
  • Unable to complete the required interpretation tasks or the 14 ± 3 day washout interval.
  • Withdrawal of consent before completion of study procedures.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Diagnóstico
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Sequence A

Period 1: library X interpreted without AI assistance and library Y interpreted with AI assistance. Period 2, after a 14 ± 3 day washout: library X interpreted with AI assistance and library Y interpreted without AI assistance.

A frozen PACE-Former model provides a predicted anaerobic threshold time within the CPET review interface. Physicians retain responsibility for the final classification and AT time annotation. No other model output or reference label is displayed.

The physician reviews the same de-identified CPET data using the study interface without display of any model prediction or AI-generated suggestion and independently classifies AT status and records the AT time when confirmed.

Experimental: Sequence B

Period 1: library X interpreted with AI assistance and library Y interpreted without AI assistance. Period 2, after a 14 ± 3 day washout: library X interpreted without AI assistance and library Y interpreted with AI assistance.

A frozen PACE-Former model provides a predicted anaerobic threshold time within the CPET review interface. Physicians retain responsibility for the final classification and AT time annotation. No other model output or reference label is displayed.

The physician reviews the same de-identified CPET data using the study interface without display of any model prediction or AI-generated suggestion and independently classifies AT status and records the AT time when confirmed.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Difference in Absolute Anaerobic Threshold Localization Error
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Absolute difference, in seconds, between the physician-selected AT time and the prespecified expert reference AT time. The primary estimand is the within-physician difference between AI-assisted and unassisted interpretations, analyzed across the same examinations using a crossed mixed-effects model.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Signed Anaerobic Threshold Localization Error
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Signed difference, in seconds, between the physician-selected AT time and the prespecified expert reference AT time. Negative values indicate earlier placement and positive values indicate later placement relative to the reference.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
Proportion of Anaerobic Threshold Estimates Within 15 Seconds of the Reference
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Proportion of interpretable examinations for which the physician-selected AT time is within 15 seconds, in either direction, of the prespecified expert reference AT time.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
Proportion of Anaerobic Threshold Estimates Within 30 Seconds of the Reference
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Proportion of interpretable examinations for which the physician-selected AT time is within 30 seconds, in either direction, of the prespecified expert reference AT time.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
Agreement With the Reference Anaerobic Threshold Status
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Agreement between the physician classification (AT confirmed, AT not reached, or unable to confirm) and the prespecified expert reference classification. Results will be summarized as overall agreement and condition-specific classification performance.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
Inter-Reader Reliability
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Reliability among physicians for AT timing and AT-status classification under AI-assisted and unassisted conditions, summarized using appropriate intraclass correlation and chance-corrected agreement statistics with 95% confidence intervals.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
Interpretation Time per Examination
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Elapsed time, in seconds, from opening the blinded CPET task to submission of the physician's AT classification and, when applicable, the selected AT time.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
Interaction Between AI Assistance and Physician Seniority
Periodo de tiempo: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Difference in the effect of AI assistance between senior and junior physicians, estimated from the prespecified assistance-by-seniority interaction term in the crossed mixed-effects model for absolute AT localization error.

Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Cong Wang, MD, PhD, Fudan University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

25 de septiembre de 2026

Finalización primaria (Estimado)

25 de noviembre de 2026

Finalización del estudio (Estimado)

25 de noviembre de 2026

Fechas de registro del estudio

Enviado por primera vez

16 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

16 de septiembre de 2026

Publicado por primera vez (Actual)

22 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

22 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

16 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir